Antihypertensive therapy in renal dysfunction

Sadayoshi Ito

Research output: Contribution to journalReview articlepeer-review


Antihypertensive treatment is essential to prevention and inhibition of cardiovascular accidents and nephropathy in diabetic patients. Studies have shown that inhibition of the renin-angiotensin system(RAS) exerts beneficial effects beyond its blood pressure-lowing action. In patients with renal dysfunction, RAS inhibition occasionally causes further decline in renal function and hyperkalemia. Because of this, general physicians may hesitate to prescribe RAS inhibitors to patients with renal dysfunction. However, clinical studies have clearly shown that RAS inhibition is particularly beneficial in those patients. This article discusses the conditions associated with RAS inhibition-induced decline in renal function and measures to take against them. In addition, combination therapy with other classes of anti-hypertensives according to renal function and proteinuria is discussed.

Original languageEnglish
Pages (from-to)1210-1218
Number of pages9
JournalNippon rinsho. Japanese journal of clinical medicine
Issue number7
Publication statusPublished - 2003 Jan 1

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Antihypertensive therapy in renal dysfunction'. Together they form a unique fingerprint.

Cite this